Funds and ETFs H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Healthcare Facilities & Services

Delayed Japan Exchange 20:36:51 2024-05-01 EDT 5-day change 1st Jan Change
2,278 JPY -0.22% Intraday chart for H.U. Group Holdings, Inc. -5.26% -14.74%

ETFs positioned on H.U. Group Holdings, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.17% 19 M€ +3.89%
0.05% 81 M€ +15.72%
0.05% 73 M€ +18.87%
0.04% 5,115 M€ +15.75%
0.04% 10,207 M€ +16.22%
0.03% 18 M€ +16.15% -
0.03% 20,721 M€ +15.02% -
0.03% 144,586 M€ +16.12%
0.03% 66,066 M€ +16.20% -
0.03% 26 M€ +21.71%
0.02% 4 M€ +16.67%
0.02% 60 M€ +15.56%
0.01% 7 M€ +2.58% -
0.01% 773 M€ -.--% -
0.01% 10 M€ -3.35% -
0.00% 31 M€ +2.76% -
0.00% 389 M€ +6.58% -
0.00% 34 M€ +6.29% -
0.00% 39 M€ +4.22% -
0.00% 302 M€ +3.73% -
0.00% 34 M€ +1.32% -
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
2,283 JPY
Average target price
2,542 JPY
Spread / Average Target
+11.34%
Consensus
  1. Stock Market
  2. Equities
  3. 4544 Stock
  4. Funds and ETFs H.U. Group Holdings, Inc.